Characterization of β-domains in C-terminal fragments of TDP-43 by scanning tunneling microscopy

Journal of Structural Biology

Volumn 181, Issue 1, 2013, Pages 11-16

  Xu, Meng ^a   Zhu, Li ^b   Liu, Jianghong ^b   Yang, Yanlian ^a   Wu, Jane Y ^b,c   Wang, Chen ^a  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Domain; Amyloid; Fibril formation; STM; TAR DNA binding protein 43

Indexed keywords

MUTANT PROTEIN; TAR DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; FRONTOTEMPORAL DEMENTIA; MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SCANNING TUNNELING MICROSCOPY; WILD TYPE;

AMINO ACID SEQUENCE; AMYLOID; AMYOTROPHIC LATERAL SCLEROSIS; DNA-BINDING PROTEINS; HUMANS; MICROSCOPY, SCANNING TUNNELING; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

EID: 84870916853     PISSN: 10478477     EISSN: 10958657     Source Type: Journal    
DOI: 10.1016/j.jsb.2012.10.011     Document Type: Article

References (27)

1. Arai T., Mackenzie I.R., Hasegawa M., Nonoka T., Niizato K., Tsuchiya K., et al. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol. 2009, 117:125-136.
2. Barmada S.J., Skibinski G., Korb E., Rao E.J., Wu J.Y., Finkbeiner S. Cytoplasmic mislocalization of TDP-43 Is toxic to neurons & enhanced by a mutation associated with familial ALS. J. Neurosci. 2010, 30:639-649.
3. Chen-Plotkin A.S., Lee V.M.-Y., Trojanowski J.Q. TAR DNA-binding protein 43 in neurodegenerative disease. Nat. Rev. Neurol. 2010, 6:211-220.
4. Cohen T.J., Lee V.M., Trojanowski J.Q. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol. Med. 2011, 17:659-667.
5. Guo W.R., Chen Y.B., Zhou X.H., Kar A., Ray P., Chen X.P., et al. An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat. Struct. Mol. Biol. 2011, 18:822-830.
6. Hasegawa M., Arai T., Nonaka T., Kametani F., Yoshida M., Hashizume Y., et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 2008, 64:60-70.
7. Hutchinson E.G., Thornton J.M. A revised set of potentials for beta-turn formation in proteins. Protein Sci. 1994, 3:2207-2216.
8. gaz L.M., Kwong L.K., Xu Y., Truax A.C., Uryu K., Neumann M., et al. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol. 2008, 173:182-194.
9. Igaz L.M., Kwong L.K., Chen-Plotkin A., Winton M.J., Unger T.L., Xu Y., et al. Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J. Biol. Chem. 2009, 284:8516-8524.
10. Kadokura A., Yamazaki T., Lemere C.A., Takatama M., Okamoto K. Regional distribution of TDP-43 inclusions in Alzheimer's disease (AD) brains: their relation to AD common pathology. Neuropathology 2009, 29:566-573.
11. Kuo P.H., Doudeva L.G., Wang Y.T., Shen C.K.J., Yuan H.S. Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res. 2009, 37:1799-1808.
12. Lagier-Tourenne C., Polymenidou M., Cleveland D.W. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010, 19(R1):R46-R64.
13. Liu L., Zhang L., Mao X.B., Niu L., Yang Y.L., Wang C. Chaperon-mediated single molecular approach toward modulating Aβ peptide aggregation. Nano Lett. 2009, 9:4066-4072.
14. Liu L., Zhang L., Niu L., Xu M., Mao X.B., Yang Y.L., et al. Observation of reduced cytotoxicity of aggregated amyloidogenic peptides with chaperone-like molecules. ACS Nano 2011, 5:6001-6007.
15. Ma X.J., Liu L., Mao X.B., Niu L., Deng K., Wu W.H., et al. Amyloid-β (1-42) folding multiplicity and single molecule binding behavior studied by STM. J. Mol. Biol. 2009, 388:894-901.
16. Mackenzie I.R.A., Neumann M., Bigio E.H., Cairns N.J., Alafuzoff I., Kril J., et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010, 119:1-4.
17. Mao X.B., Ma X.J., Liu L., Niu L., Yang Y.L., Wang C. Structural characteristics of the beta-sheet-like human and rat islet amyloid polypeptides as determined by scanning tunneling microscopy. J. Struct. Biol. 2009, 167:209-215.
18. Mao X.B., Wang C.X., Wu X.K., Ma X.J., Liu L., Zhang L., et al. Beta structure motifs of islet amyloid polypeptides identified through surface-mediated assemblies. Proc. Natl. Acad. Sci. USA 2011, 108:19605-19610.
19. Mao X.B., Guo Y.Y., Wang C.X., Zhang M., Ma X.J., Liu L., et al. Binding modes of thioflavin t molecules to prion peptide assemblies identified by using scanning tunneling microscopy. ACS Chem. Neurosci. 2011, 2:281-287.
20. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
21. Piao Y.S., Wakabayashi K., Kakita A., Yamada M., Hayashi S., Morita T., et al. Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol. 2003, 13:10-22.
22. Rose G.D., Gierasch L.M., Smith J.A. Turns in peptides and proteins. Adv. Protein Chem. 1985, 37:1-109.
23. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
24. Wang I.F., Wu L.S., Chang H.Y., Shen C.K.J. TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J. Neurochem. 2008, 105:797-806.
25. Wang C.X., Mao X.B., Yang A.H., Niu L., Wang S.N., Li D.H., et al. Determination of relative binding affinities of labeling molecules with amino acids by using scanning tunneling microscopy. Chem. Commun. 2011, 47:10638-10640.
26. Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA 2009, 106:18809-18814.
27. Zhang Y.J., Xu Y.F., Cook C., Gendron T.F., Roettges P., Link C.D., et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA 2009, 106:7607-7612.